Home / Health / Parkinson's Pill Offers Longer Symptom Control
Parkinson's Pill Offers Longer Symptom Control
7 Oct
Summary
- An experimental pill for Parkinson's disease shows promise.
- The drug, solengepras, extends daily symptom control periods.
- Patients experienced reduced 'off-time' medication effects.
An experimental pill developed by Cerevance Ltd. is offering new hope for individuals managing Parkinson's disease. The drug, known as solengepras, has demonstrated an ability to provide patients with longer periods of symptom control each day.
This innovation focuses on reducing the duration of "off-time," which refers to the intervals when a patient's medication for Parkinson's disease begins to wear off. The extended symptom management provided by solengepras could represent a significant advancement in treatment options for Parkinson's patients.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
